Orbimed Advisors LLC Adagene Inc. Transaction History

Orbimed Advisors LLC

  • $4.44 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$3.5 - $8.79 $921,116 - $2.31 Million
-263,176 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$7.4 - $14.44 $87,497 - $170,738
-11,824 Reduced 4.3%
263,176 $2.12 Million
Q1 2021

May 17, 2021
BUY
$17.0 - $29.99 $4.68 Million - $8.25 Million
275,000 New
275,000 $4.94 Million

Others Institutions Holding ADAG

# of Institutions
17
Shares Held
10.9M
Call Options Held
0
Put Options Held
0
View Full List

About Adagene Inc.

ADAG Quotes by TradingView
  • Ticker ADAG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,423,200
  • Market Cap $122M
  • Description
  • Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid ...
More about ADAG
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email